CNIO researchers obtain the first mice born with hyper-long telomeres

October 17, 2019

A chance finding ten years ago led to the creation by researchers of the Spanish National Cancer Research Centre (CNIO) of the first mice born with much longer telomeres than normal in their species. Given the relationship between telomeres and ageing - telomeres shorten throughout life, so older organisms have shorter telomeres -, scientists launched a study generating mice in which 100% of their cells had hyper-long telomeres. The findings are published in Nature Communications and show only positive consequences: the animals with hyper-long live longer in better health, free from cancer and obesity. The most relevant thing for the authors is the fact that longevity has been significantly increased for the first time ever without any genetic modification.

"This finding supports the idea that, when it comes to determining longevity, genes are not the only thing to consider", indicates Maria Blasco, Head of the CNIO Telomeres and Telomerase Group and intellectual author of the paper. "There is margin for extending life without altering the genes".

Telomeres form the end of chromosomes, in the nucleus of each cell in the body. Their function is to protect the integrity of the genetic information in DNA. Whenever the cells divide the telomeres, they are shortened a little, so one of the main characteristics of ageing is the accumulation of short telomeres in cells. "Telomere shortening is considered to be one of the primary causes of ageing, given that short telomeres cause ageing of the organism and reduce longevity", as the paper published in Nature Communications explains.

The CNIO Telomeres and Telomerase Group has already shown in diverse studies that avoiding the shortening of telomeres through the activation of the telomere lengthening enzyme, telomerase, extends longevity without any secondary effects.

However, up to now, all interventions on the length of telomeres have been based on altering the expression of genes, through one technique or another. In fact, some years ago, the CNIO group developed a gene therapy that fosters the synthesis of telomerase, obtaining mice that live 24% longer without developing cancer of other illnesses associated with age.

13% longer, slimmer and free from cancer

The new thing is that there has been no genetic alteration in the mice born with hyper-long telomeres. In 2009, researchers worked with the so-called IPS cells -cells from an adult organism which have been given back pluripotency or the capacity to generate a full organism -, and they observed that after a certain number of divisions in culture plates, these cells acquired telomeres twice as long as normal. Intrigued, they confirmed that the same occurred in normal embryonic cells -also pluripotent-, as they are kept in cultivation after being removed from the blastocyst.

On researching the phenomenon, Blasco's team found that during the pluripotency stage, there are certain biochemical marks (epigenetic marks) on the telomeric chromatin that facilitate their lengthening by the telomerase enzyme. For this reason, the telomeres of pluripotency cells in cultivation were extended to twice the normal length.

The question was, whether the embryonic cells with hyper-long telomeres could produce live mice? Some years ago, the group demonstrated that they could, whereby this research was also published in Nature Communications. However, these first animals were chimerical, or in other words, only part of their cells - between 30% and 70%- came from embryonic cells with hyper-long telomeres. Their good health may be attributed to the proper functioning of the rest of the cells, with normal telomeres.

In the study that has now been published, the authors have managed to obtain hyper-long telomeres in 100% of mice cells, whereby this entire peculiar feature is attributable to this phenomenon. Indeed, there are many peculiarities.

"Unprecedented results"

"These mice have less cancer and live longer", according to the authors. "An important fact is that they are slimmer than normal because they accumulate less fat. They also show lower metabolic ageing, with lower levels of cholesterol and LDL (bad cholesterol), and an increased tolerance to insulin and glucose. Damage to their DNA as they age is less and their mitochondria, another Achilles heel of ageing, function better.

In conclusion, "these unprecedented results show that longer than normal telomeres in a given species are not harmful but quite the contrary: they have beneficial effects, such as increased longevity, delayed metabolic age and less cancer".

More specifically, the average longevity of mice with hyper-long telomeres is 13% higher than usual. The metabolic alterations observed are also relevant as this is the first time that a clear relationship between the length of telomeres and metabolism has been found. The genetic route of insulin and glucose metabolism is identified as one of the most important in relation to ageing.

However, what is most striking for researchers is that this finding paves the way for extending longevity without changing the genes of the organism. Biochemical changes in the telomeric chromatin that facilitates the lengthening of telomeres in the pluripotency phase is epigenetic, or in other words, it acts as a chemical annotation that modifies the work of genes, but does not alter their essence. "Extending the time during which embryonic cells remain in pluripotency to generate mice with longer telomeres, protected from cancer and obesity, and with increased longevity has been enough to make mice have longer telomeres and live longer", point out the authors. "We present a new model of mouse in which ageing has been delayed without any genetic manipulation".
The study has been funded by the Spanish Ministry of Science, Innovation and Universities, the National Institute of Health Carlos III, the Community of Madrid, the Botín Foundation and Banco Santander through Santander Universities, and World Cancer Research.

Reference article:Mice with hyper-long telomeres show less metabolic aging and longer lifespans. Miguel A. Muñoz-Lorente, Alba C. Cano-Martin, Maria A. Blasco (Nature Communications, 2019). DOI: 10.1038/s41467-019-12664-x

Centro Nacional de Investigaciones Oncológicas (CNIO)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to